Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.

Huang G, Xu JB, Liu JX, He Y, Nie XL, Li Q, Hu YM, Zhao SQ, Wang M, Zhang WY, Liu XR, Wu T, Arkin A, Zhang TJ.

Eur J Clin Invest. 2011 Jul;41(7):719-33. doi: 10.1111/j.1365-2362.2010.02460.x. Epub 2011 Jan 20. Review.

PMID:
21250983
2.

The role of renin-angiotensin system blockade therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.

Zhang Y, Zhang P, Mu Y, Gao M, Wang JR, Wang Y, Su LQ, Hou YL.

Clin Pharmacol Ther. 2010 Oct;88(4):521-31. doi: 10.1038/clpt.2010.123. Epub 2010 Sep 1.

PMID:
20811347
3.

Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation.

Kuzniatsova N, Shantsila E, Lip GY.

Nat Rev Cardiol. 2010 Aug;7(8):428-30. doi: 10.1038/nrcardio.2010.103. No abstract available.

PMID:
20657612
4.

Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis.

Jibrini MB, Molnar J, Arora RR.

Am J Ther. 2008 Jan-Feb;15(1):36-43. doi: 10.1097/MJT.0b013e31804beb59. Review.

PMID:
18223352
5.

[Are ACE inhibitors and angiotensin receptor blockers useful in the treatment of atrial fibrillation?].

Raatikainen MJ, Huikuri HV.

Duodecim. 2003;119(16):1505-7. Finnish. No abstract available.

PMID:
14535023
6.

Drug therapy for atrial fibrillation.

Conway EL, Musco S, Kowey PR.

Cardiol Clin. 2009 Feb;27(1):109-23, ix. doi: 10.1016/j.ccl.2008.10.003.

PMID:
19111768
7.

Role of renin-angiotensin system inhibitors in atrial fibrillation.

Disertori M, Latini R, Maggioni AP.

J Cardiovasc Med (Hagerstown). 2011 May;12(5):374; author reply 375. doi: 10.2459/JCM.0b013e328343d3de. No abstract available.

PMID:
21451337
8.

Focus on renin-angiotensin system modulation and atrial fibrillation control after GISSI AF results.

Durin O, Pedrinazzi C, Inama G.

J Cardiovasc Med (Hagerstown). 2010 Dec;11(12):912-8. doi: 10.2459/JCM.0b013e32833cdd6f. Review.

PMID:
20729747
9.

Prevention of recurrent atrial fibrillation with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a systematic review and meta-analysis of randomized trials.

Bhuriya R, Singh M, Sethi A, Molnar J, Bahekar A, Singh PP, Khosla S, Arora R.

J Cardiovasc Pharmacol Ther. 2011 Jun;16(2):178-84. doi: 10.1177/1074248410389045. Epub 2011 Feb 1. Review.

PMID:
21285399
10.

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, Connolly SJ.

J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9.

11.

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.

Zheng B, Kang J, Tian Y, Tang R, Long D, Yu R, He H, Zhang M, Shi L, Tao H, Liu X, Dong J, Ma C.

Acta Cardiol. 2009 Jun;64(3):335-40.

12.
13.

Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis.

Schneider MP, Hua TA, Böhm M, Wachtell K, Kjeldsen SE, Schmieder RE.

J Am Coll Cardiol. 2010 May 25;55(21):2299-307. doi: 10.1016/j.jacc.2010.01.043. Review.

14.

The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.

Madrid AH, Peng J, Zamora J, Marín I, Bernal E, Escobar C, Muños-Tinoco C, Rebollo JM, Moro C.

Pacing Clin Electrophysiol. 2004 Oct;27(10):1405-10.

PMID:
15511250
15.

Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.

Makkar KM, Sanoski CA, Spinler SA.

Pharmacotherapy. 2009 Jan;29(1):31-48. doi: 10.1592/phco.29.1.31. Review.

PMID:
19113795
16.

Renin-angiotensin system inhibitors prevent the recurrence of atrial fibrillation: a meta-analysis of randomized controlled trials.

Han M, Zhang Y, Sun S, Wang Z, Wang J, Xie X, Gao M, Yin X, Hou Y.

J Cardiovasc Pharmacol. 2013 Oct;62(4):405-15. doi: 10.1097/FJC.0b013e3182a094a1. Review.

PMID:
23921300
18.
19.
20.

Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.

Coleman CI, Makanji S, Kluger J, White CM.

Ann Pharmacother. 2007 Mar;41(3):433-7. Epub 2007 Mar 6.

PMID:
17341525
Items per page

Supplemental Content

Write to the Help Desk